Lysozyme Substrate Detection for Synovial Joint Infections
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for detecting synovial joint infections are unreliable and time-consuming, often resulting in delayed diagnosis and inappropriate treatment, as they cannot distinguish between bacterial infections and non-infectious inflammatory conditions, posing a risk of spreading pathogens and causing irreversible joint damage.
Innovation Solution
A method involving the use of lysozyme substrates to detect lysozyme activity in synovial fluid samples, which differentiates between synovial joint infections and non-infectious inflammatory conditions by measuring enzymatic activity, allowing for rapid identification of bacterial infections using a simple and rapid color reaction system.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If synovial fluid is cultured on special culture media in an incubator to detect bacterial infection, then the detection can be performed, but the process takes 2 to 5 days and produces up to 30% false negative results
Solution Approach 1:
The patent replaces the traditional mechanical/cultural detection system (incubator-based bacterial culture) with an enzymatic detection system using lysozyme activity measurement. This substitution enables rapid detection within minutes while eliminating false negatives, as lysozyme is directly released by bacteria and its activity can be immediately measured through colorimetric assays with substrates like MUG or ONPG.
Solution Approach 2:
The patent changes the detection parameter from bacterial colony formation (which requires days of incubation) to lysozyme enzymatic activity (which can be measured immediately). By measuring the hydrolysis rate of lysozyme substrates, the system provides rapid and accurate detection without the time delays and false negatives associated with traditional culture methods.
2Measurement precision
If traditional detection methods are used to identify synovial joint infections, then the process can be completed, but it cannot reliably distinguish between bacterial infections and non-infectious inflammatory conditions
Solution Approach 1:
The patent introduces lysozyme as a specific intermediary marker that mediates between the presence of bacteria and the detection signal. Since lysozyme is directly released by bacteria during infection but not activated in non-infectious inflammation, it serves as a precise discriminator that simplifies the detection system while improving differentiation accuracy between infectious and non-infectious conditions.
Solution Approach 2:
The patent employs colorimetric detection using lysozyme substrates such as MUG (4-methylumbelliferone-β-D-glucuronide) or ONPG (o-nitrophenyl-β-D-galactopyranoside). When lysozyme hydrolyzes these substrates, they produce fluorescent or colored products that can be easily detected, providing a simple visual or spectrophotometric readout that enhances measurement precision without increasing system complexity.
3Productivity
If rapid detection of synovial joint infections is implemented, then immediate treatment can be initiated, but reliable differentiation from non-infectious inflammation is required to avoid inappropriate antibiotic administration
Solution Approach 1:
The patent replaces slow, imprecise traditional detection methods with a rapid enzymatic assay system that measures lysozyme activity directly. This substitution achieves both rapid diagnosis (within minutes) and high precision differentiation, as the enzymatic reaction provides immediate quantifiable results that clearly distinguish bacterial infections from non-infectious conditions based on lysozyme presence and activity levels.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables immediate and accurate differentiation between bacterial and inflammatory joint conditions, facilitating appropriate treatment and reducing the risk of complications by providing a rapid diagnostic tool that does not require extensive laboratory procedures.
Implementation Method 1
contacting a synovial fluid sample with at least one lysozyme substrate, and detecting a synovial joint infection when a conversion of said at least one substrate is determined
Data Source
Figure 1
Figure 2
Figure 3
AI summary
The present invention relates to a method for detecting a synovial joint infection comprising the steps of - contacting a synovial fluid sample with at least one lysozyme substrate, and - detecting a synovial joint infection when a conversion of said at least one substrate is determined